Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011997
Abstract: Rationale: Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. Platelets typically reach normal levels 7 days after LZD withdrawal. However, recurrent profound thrombocytopenia due to LZD usage and… read more here.
Keywords: thrombocytopenia; recurrent profound; profound thrombocytopenia; thrombocytopenia due ... See more keywords